We are pleased to share the good news that Dr. Sriram Padmanabhan, Professor, TDU has been selected as one of only 5 scientists from all over India to be awarded the “Tata Innovation Fellowship”, a highly competitive scheme, instituted by the Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India.
The prestigious Tata Innovation Fellowship recognizes and rewards scientists with outstanding track record in biological sciences with a deep commitment to find innovative solutions to major problems in health care, agriculture and other areas related to life sciences and biotechnology. It is aimed at rewarding scientists with outstanding contribution and publication on products or ideas based on innovation and translational research with a potential towards commercialisation and the award carries a monthly fellowship and a fixed contingency grant for a period of three years.
Dr. Sriram’s major achievements are related to his efforts to launch recombinant granulocyte colony stimulating factor (rhGCSF) the first biosimilar drug in India in the year 2000. Also, he is the innovator of a novel bacteriophage derived protein- P128 that kills all strains of Staphylococcus aureus including the multi-drug resistant S. aureus, and is now a clinical stage molecule. The latter work has yielded several US patents to his credit. Dr. Sriram from Lupin Biotechnology Ltd, Pune developed several biosimilars, expressed in proprietary microbial systems and MAbs in mammalian expression systems, of which GCSF, PEG-GCSF and Etanercept are in the market, on date.
Currently, Dr. Sriram is interested to bring traditional Indian (Ayurveda) treatments for diseases such as Autism, Alzheimer’s, bacterial infections, and cancer, into mainstream medical practice, through the use of modern analytical methodologies in research and PoC studies.
TDU joins the community of scientists in congratulating Dr Sriram for this achievement and wishes him more such honours in the future. Dr Sriram can be contacted at firstname.lastname@example.org or email@example.com